Pathological microscopes are utilized in the diagnostic centers for diagnosis of infectious and chronic diseases. More precisely, it is used to examine cells and body fluids in the laboratory and assess, type, quantity, and characteristics of the blood cells.
The growing use of pathological microscopes in the drug discovery, increasing prevalence of the infectious and chronic diseases, growing automation in the laboratories and growth in number of private and public diagnostic centers are major drivers driving the market growth. Though, unfavourable reimbursement policies and the high cost associated with the microscopes constrain growth of the market.
Segment Overview
Growing use of pathological microscopes in the drug discovery is anticipated to drive growth of market. Pharmaceutical industry is observing rapid change in the technology due to growing research and development activities lead by the private as well as the public partners. Majority of players in pharmaceutical market are capitalizing huge money in development of the new drugs. With growing research and development activities, use and demand for the advanced instruments including pathological microscopes in pharmaceutical industry are growing.
Growing pathological microscopes in the drug discovery is the primary factor accelerating growth of market. According to International Federation of the Pharmaceutical Manufacturers and Associations, in 2015, global pharmaceutical industry expended over USD 149.8 billion on the research and development activities. Furthermore, rising prevalence of the chronic and infectious diseases, growing automation in laboratories fuelled the growth of market. Moreover, growth in number of public and private diagnostic facilities are likely to upkeep the market growth. On the other hand, high costs associated with the microscopes and unfavourable reimbursement policies is expected to hamper market growth.
Regional Overview
The North America is projected to dominate global pathological microscopes market over the forecast period. This is accredited to developed healthcare infrastructure, rising number of the academic institutes, and growing research and development activities in this region.
The market for the pathological microscopes in the Europe is anticipated to be second-largest during forecast period, owing to the factors such as support provided by the government bodies for healthcare sector, growths in life science sector and swelling research and development activities. Moreover, companies operating in market are mainly concentrating on the mergers and acquisition, which is anticipated to support the market growth.
Asia-Pacific is projected to be fastest-growing market due to developing healthcare infrastructure and the growing disposable income. Additionally, growing healthcare infrastructure has augmented the number of various research activities in the region.
Competitor overview
In August 2018, company, Nikon Corporation announced launch of A1R HD25 confocal microscope. This microscope with high resolution and the high-throughput and is recognised as world's largest twenty five mm field view confocal microscope.
In June 2018, company Olympus Corporation announced its partnership with the MedTech innovator to increase the clinical outcomes and also to reduce the overall cost coupled with improved quality.
In March 2017, company Hitachi High-Technologies Corporation opened the High-Tech Science Park Shanghai Lab in the city Shanghai. This helped company develop and sell the analytical instruments in Chinese market.
Key Players
- Nikon Corporation
- Leica Biosystems Nussloch GmbH
- Olympus Corporation
- ZEISS International
- Sakura Finetek USA, Inc.
- Celestron, LLC.
- Labomed Inc.
- Hitachi High-Technologies Corporation
- Bruker Corporation
- Euromex Microscopen BV
Market Segmentation
By Type
- Compound Microscope
- Electron Microscope
- Optical Microscope
- Digital Microscope
- Fluorescence Microscope
- Others
- Pathology & Diagnostic laboratories
- Forensic Laboratories
- Hospitals & Clinics
- Others
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- UAE
- Rest of LAMEA
Table of Contents
1 Report Prologue 12
2 Executive Summary 14
3 Market Introduction 17
- 3.1 Definition 18
- 3.2 Scope of the Study 18
- 3.3 Assumptions & Limitations 18
- 3.3.1 Assumptions 18
- 3.3.2 Limitations 18
- 3.4 Market Structure 19
4 Research Methodology 20
- 4.1 Research Process 21
- 4.2 Primary Research 22
- 4.3 Secondary Research 23
- 4.4 Market Size Estimation 24
- 4.5 Forecast Model 24
5 Market Dynamics 25
- 5.1 Introduction 26
- 5.2 Drivers 27
- 5.2.1 Increasing use of pathological microscopes in drug discovery 27
- 5.2.2 Rising Prevalence of Chronic and Infectious Diseases 27
- 5.2.3 Increasing automation in laboratories 27
- 5.2.4 Growth in the number of public and private diagnostic centers 27
- 5.3 Restraints 28
- 5.3.1 Unfavorable reimbursement policies 28
- 5.3.2 High cost associated with microscopes 28
- 5.4 Opportunity 28
- 5.4.1 Increasing use of telepathology and telemedicine 28
- 5.5 Challenges 28
- 5.5.1 Time-consuming sample preparation process 28
- 5.5.2 Requirement of a high degree of technical expertise 29
6 Market Factor Analysis 30
- 6.1 Porter’s Five Forces Model 31
- 6.1.1 Bargaining Power of Suppliers 31
- 6.1.2 Bargaining Power of Buyers 31
- 6.1.3 Threat of New Entrants 32
- 6.1.4 Threat of Substitutes 32
- 6.1.5 Intense Rivalry 32
- 6.2 Value Chain Analysis 32
- 6.2.1 R&D 32
- 6.2.2 Product Development 32
- 6.2.3 Manufacturing 33
- 6.2.4 Marketing and Distribution 33
7 Global Pathological Microscopes Market, By Type 34
- 7.1 Introduction 35
- 7.2 Electron Microscope 36
- 7.3 Optical Microscope 37
- 7.4 Compound Microscope 38
- 7.5 Digital Microscope 39
- 7.6 Fluorescence Microscope 39
8 Global Pathological Microscopes Market, By Application 40
- 8.1 Introduction 41
- 8.2 Bodily Fluids 42
- 8.3 Tissue Scanning 43
9 Global Pathological Microscopes Market, By End User 44
- 9.1 Introduction 45
- 9.2 Pathology and Diagnostic Laboratories 46
- 9.3 Hospitals & Clinics 47
- 9.4 Forensic Laboratories 47
10 Global Pathological Microscopes Market, By Region 48
- 10.1 Introduction 49
- 10.2 Americas 50
- 10.2.1 North America 52
- 10.2.1.1 U.S. 54
- 10.2.1.2 Canada 55
- 10.2.2 South America 56
- 10.2.1 North America 52
- 10.3 Asia Pacific 57
- 10.3.1 Japan 59
- 10.3.2 China 60
- 10.3.3 India 61
- 10.3.4 Republic of Korea 62
- 10.3.5 Australia 63
- 10.3.6 Rest of Asia Pacific 64
- 10.4 Europe 65
- 10.4.1 Western Europe 67
- 10.4.1.1 Germany 68
- 10.4.1.2 U.K 69
- 10.4.1.3 France 70
- 10.4.1.4 Italy 71
- 10.4.1.5 Spain 72
- 10.4.1.6 Rest of Western Europe 73
- 10.4.2 Eastern Europe 74
- 10.4.1 Western Europe 67
- 10.5 The Middle East and Africa 76
- 10.5.1 Middle east 78
- 10.5.2 Africa 79
11 Competitive Landscape 80
- 11.1 Company Market Share Analysis 81
- 11.2 Introduction 81
12 Company Profiles 82
- 12.1 Nikon Corporation 83
- 12.1.1 Company Overview 83
- 12.1.2 Financial Overview 83
- 12.1.3 Products/Services Offered 84
- 12.1.4 SWOT Analysis 84
- 12.1.5 Key Developments 84
- 12.1.6 Key strategy 84
- 12.2 Leica Biosystems Nussloch GmbH 85
- 12.2.1 Company Overview 85
- 12.2.2 Financial Overview 85
- 12.2.3 Products/Services Offered 86
- 12.2.4 SWOT Analysis 86
- 12.2.5 Key Developments 86
- 12.2.6 Key strategy 86
- 12.3 Olympus Corporation 87
- 12.3.1 Company Overview 87
- 12.3.2 Company Overview 87
- 12.3.3 Products/Services Offered 88
- 12.3.4 SWOT Analysis 88
- 12.3.5 Key Developments 88
- 12.3.6 Key strategy 88
- 12.4 ZEISS International 89
- 12.4.1 Company Overview 89
- 12.4.2 Financial Overview 89
- 12.4.3 Products/Services Offered 90
- 12.4.4 SWOT Analysis 90
- 12.4.5 Key Developments 90
- 12.4.6 Key Strategy 91
- 12.5 Labomed, Inc. 92
- 12.5.1 Company Overview 92
- 12.5.2 Financial Overview 92
- 12.5.3 Products/Services Offered 92
- 12.5.4 Key Developments 92
- 12.5.5 SWOT Analysis 93
- 12.5.6 Key Strategy 93
- 12.6 Hitachi High-Technologies Corporation 94
- 12.6.1 Company Overview 94
- 12.6.2 Financial Overview 94
- 12.6.3 Products/Services Offered 95
- 12.6.4 Key Developments 95
- 12.6.5 SWOT Analysis 95
- 12.6.6 Key Strategy 95
- 12.7 Euromex Microscopen BV 96
- 12.7.1 Company Overview 96
- 12.7.2 Financial Overview 96
- 12.7.3 Products/Services Offered 96
- 12.7.4 Key Developments 96
- 12.7.5 SWOT Analysis 96
- 12.7.6 Key Strategy 96
- 12.8 Bruker Corporation 97
- 12.8.1 Company Overview 97
- 12.8.2 Financial Overview 97
- 12.8.3 Products/Services Offered 98
- 12.8.4 Key Developments 98
- 12.8.5 SWOT Analysis 98
- 12.8.6 Key Strategy 98
- 12.9 Sakura Finetek USA, Inc. 99
- 12.9.1 Company Overview 99
- 12.9.2 Financial Overview 99
- 12.9.3 Products/Services Offered 99
- 12.9.4 SWOT Analysis 99
- 12.9.5 Key Developments 99
- 12.9.6 Key strategy 99
- 12.10 Celestron, LLC 100
- 12.10.1 Company Overview 100
- 12.10.2 Financial Overview 100
- 12.10.3 Products/Services Offered 100
- 12.10.4 SWOT Analysis 100
- 12.10.5 Key Developments 101
- 12.10.6 Key strategy 101
13 Appendix 102
- 13.1 Discussion Blue Print 103
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
